Monday 31 March, 2008

Pharma firms bet big on new B'desh law

The business standard reported an article by Joe C Mathew on Domestic drug firms, which lost the opportunity to sell cheap generic versions of patented medicines after changes in the Indian patent law three years ago, may find favorable market in Bangladesh. Chances of technical partnerships in Bangladesh have brightened after it changed its patent law in an attempt to become a hub for manufacturing cheap copies of patent-protected medicines. The World Trade Organisation allows such medicines to be produced in least developed countries till 2016. ( Link to full article business-standard.)

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker